
Out of the 20 top biopharmaceutical companies, 16 reported a drop in quarter-on-quarter (QoQ) market capitalization where eight companies saw…
According to IQVIA MAT October 2022, Rufinamide Tablets (RLD Banzel) had estimated annual sales of USD 138 million in the…
According to industry estimates, the US generic drug market was estimated at around USD 115.2 billion in 2019. It is…
According to Mudras, as India is a strong market, there is now a need to focus on the value of…
Both therapies under the deal are antibodies that work against the TL1A protein, the excess presence of which has been…
This partnership leverages the strengths of each of the companies resulting in an innovation strategy creating a unique value proposition…
A team of doctors, nurses and technicians will be undergoing 3-6 months’ hands-on training starting from January 2023.
The medication is used to relieve joint pain from arthritis and it comes under nonsteroidal anti-inflammatory drugs (NSAIDs).
According to the company, TPE tubing is ideal for pharmaceutical bioprocessing applications because it can be welded to existing tubing…
Gland Pharma’s Singapore subsidiary Gland Pharma International PTE has entered into an agreement to acquire 100% of France-based contract development…
The launch of the app signals Roche’s goal to leverage digital platforms and mobile applications that put effective and scalable…
According to IQVIA MAT September 2022, Formoterol Fumarate Inhalation Solution (RLD Perforomist) had estimated annual sales of USD 268 million…
Chronic kidney disease (CKD) is one of the leading causes of hospitalization globally and in India, representing a significant clinical…
According to Cipla, the active ingredient, route of administration, dosage form and strength are the same as LUPRON DEPOT 22.5…
This move reinforces our commitment to making healthcare solutions accessible to all patients, the company claimed.
Poziotinib is a drug developed by Hanmi Pharmaceutical, Luye Pharma, and Spectrum Pharmaceuticals for various cancers.
However, key opinion leaders (KOLs), as per GlobalData, were unanimous in their preference to prescribe established LAIs over the new…
According to the pharma company, the final step in the path to approval in Europe is a Marketing Authorization decision…